-logo-1200x675.png?v=20230920074015&w=240&h=240&zc=2){kind=logo}
HC Wainwright Reiterates Neutral Rating for Fulcrum Therapeutics (NASDAQ:FULC)
Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They currently have a $4.00 target price on the stock. HC Wainwright’s price target suggests a potential upside of 18.69% from the stock’s current price. HC Wainwright also […]
Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They currently have a $4.00 target price on the stock. HC Wainwright’s price target suggests a potential upside of 18.69% from the stock’s current price. HC Wainwright also […]
